Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Diagnostic Radiopharmaceuticals
    • 1.2.1.2 Therapy Radiopharmaceuticals
    • 1.2.1.3 Enriched Stable Isotopes
  • 1.2.2 by Application
    • 1.2.2.1 Diagnostic Application
    • 1.2.2.2 Therapeutic Application
    • 1.2.2.3 Research
    • 1.2.2.4 Pharmaceutical
    • 1.2.2.5 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Diagnostic Radiopharmaceuticals Market, 2013-2018
  • 4.1.2 Therapy Radiopharmaceuticals Market, 2013-2018
  • 4.1.3 Enriched Stable Isotopes Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Diagnostic Radiopharmaceuticals Market Forecast, 2019-2024
  • 4.2.2 Therapy Radiopharmaceuticals Market Forecast, 2019-2024
  • 4.2.3 Enriched Stable Isotopes Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Diagnostic Application Market, 2013-2018
  • 5.1.2 Therapeutic Application Market, 2013-2018
  • 5.1.3 Research Market, 2013-2018
  • 5.1.4 Pharmaceutical Market, 2013-2018
  • 5.1.5 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Diagnostic Application Market Forecast, 2019-2024
  • 5.2.2 Therapeutic Application Market Forecast, 2019-2024
  • 5.2.3 Research Market Forecast, 2019-2024
  • 5.2.4 Pharmaceutical Market Forecast, 2019-2024
  • 5.2.5 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Bracco Imaging S.P.A.
• 8.2 Cambridge Isotope Laboratories, Inc.
• 8.3 Cardinal Health, Inc.
• 8.4 Covidien, Plc
• 8.5 Eczacibasi-Monrol
• 8.6 Fujifilm Holdings Corporation
• 8.7 GE Healthcare (Subsidiary Of General Electric Company)
• 8.8 IBA Group
• 8.9 Isotec, Inc. (Sigma-Aldrich)
• 8.10 Lantheus Medical Imaging, Inc.
• 8.11 Nordion, Inc.
• 8.12 Ntp Radioisotopes (Pty), Ltd.
• 8.13 Siemens Healthcare (Subsidiary Of Siemens AG)
• 8.14 Taiyo Nippon Sanso Corporation
• 8.15 Urenco Limited
• 8.16 Rotem Industries, Ltd., Inc.
• 8.17 Australian Nuclear Association And Technology Organization (ANSTO)
• 8.18 Board of Radiation And Isotope Technology (BRIT)
• 8.19 Institute of Atomic Energy Polatom Radioisotope Centre
• 8.20 Institute of Isotopes Co., Ltd.
• 8.21 Institute Of Radioelement (IRE)

9 Conclusion

Summary
The global Radiopharmaceuticals in Nuclear Medicine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa